US investment giant Fidelity has lifted its stake in NZX-listed medical and pharmaceutical products distributor Ebos Group [NZX: EBO] above 9%.
Boston-based Fidelity purchased 1.5 million Ebos shares between May 22 and July 10, increasing its holding from 8.06% to 9.06% according to a
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Duncan Bridgeman
Tue, 15 Jul 2014
Tue, 15 Jul 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
US fund takes a liking to Ebos Group
39594